Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Koski

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1982
Monoclonal antibody specific for myelin glycoprotein P0: derivation and characterizationM C Franko, C L Koski, C J Gibbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1987
Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosusM E Sanders, E L Alexander, C L Koski, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristicsC L Koski, L E Ramm, C H Hammer, et al.
Journal of Neurochemistry|January 1, 1996
Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteinsC L Koski, A E Estep, S Sawant-Mane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosisM E Sanders, C L Koski, D Robbins, et al.
Annals of Internal Medicine|June 15, 1993
Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndromeB Mishu, A A Ilyas, C L Koski, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2001
Use of intravenous gamma globulins in neuroimmunologic diseasesN Latov, V Chaudhry, C L Koski, et al.
The Journal of Clinical Investigation|November 1, 1987
Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathiesC L Koski, M E Sanders, P T Swoveland, et al.
Journal of the Peripheral Nervous System : JPNS|April 15, 2014
A controlled trial of intravenous immunoglobulin in multifocal motor neuropathyAngelika F Hahn, Said R Beydoun, Victoria Lawson, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|November 28, 2023
Blood lead concentrations in exposed forecourt attendants and taxi drivers in parts of South AfricaJ O Olowoyo, U A Tshoni, A S Kobyana, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1982
Monoclonal antibody specific for myelin glycoprotein P0: derivation and characterizationM C Franko, C L Koski, C J Gibbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1987
Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosusM E Sanders, E L Alexander, C L Koski, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristicsC L Koski, L E Ramm, C H Hammer, et al.
Journal of Neurochemistry|January 1, 1996
Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteinsC L Koski, A E Estep, S Sawant-Mane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosisM E Sanders, C L Koski, D Robbins, et al.
Annals of Internal Medicine|June 15, 1993
Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndromeB Mishu, A A Ilyas, C L Koski, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2001
Use of intravenous gamma globulins in neuroimmunologic diseasesN Latov, V Chaudhry, C L Koski, et al.
The Journal of Clinical Investigation|November 1, 1987
Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathiesC L Koski, M E Sanders, P T Swoveland, et al.
Journal of the Peripheral Nervous System : JPNS|April 15, 2014
A controlled trial of intravenous immunoglobulin in multifocal motor neuropathyAngelika F Hahn, Said R Beydoun, Victoria Lawson, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|November 28, 2023
Blood lead concentrations in exposed forecourt attendants and taxi drivers in parts of South AfricaJ O Olowoyo, U A Tshoni, A S Kobyana, et al.
Pageof 7